Viewing Study NCT00946335


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-05-19 @ 9:07 AM
Study NCT ID: NCT00946335
Status: COMPLETED
Last Update Posted: 2014-07-09
First Post: 2009-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Childhood Atypical Teratoid/Rhabdoid Tumor View
None Childhood Central Nervous System Germ Cell Tumor View
None Childhood Choroid Plexus Tumor View
None Childhood Craniopharyngioma View
None Childhood Ependymoblastoma View
None Childhood Grade I Meningioma View
None Childhood Grade II Meningioma View
None Childhood Grade III Meningioma View
None Childhood High-grade Cerebellar Astrocytoma View
None Childhood High-grade Cerebral Astrocytoma View
None Childhood Infratentorial Ependymoma View
None Childhood Low-grade Cerebellar Astrocytoma View
None Childhood Low-grade Cerebral Astrocytoma View
None Childhood Medulloepithelioma View
None Childhood Mixed Glioma View
None Childhood Oligodendroglioma View
None Childhood Supratentorial Ependymoma View
None Recurrent Childhood Brain Stem Glioma View
None Recurrent Childhood Brain Tumor View
None Recurrent Childhood Cerebellar Astrocytoma View
None Recurrent Childhood Cerebral Astrocytoma View
None Recurrent Childhood Ependymoma View
None Recurrent Childhood Medulloblastoma View
None Recurrent Childhood Pineoblastoma View
None Recurrent Childhood Spinal Cord Neoplasm View
None Recurrent Childhood Subependymal Giant Cell Astrocytoma View
None Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor View
None Recurrent Childhood Visual Pathway and Hypothalamic Glioma View
Keywords: